Polymorphonuclear Leukocytes (PMNs): Neutrophil Function and Clinical Significance
PMNs = Neutrophils (most abundant leukocyte, 60–70% of circulating WBCs). Multi-lobed nucleus (2–5 lobes), cytoplasmic granules.
Key Functions
- Phagocytosis: Engulf bacteria/fungi; oxidative burst (NADPH oxidase → ROS), granular enzymes (MPO, elastase, cathepsin G) → microbial killing.
- NETosis: Neutrophil extracellular traps (DNA + antimicrobial proteins) trap/kill pathogens.
- Chemotaxis: Rapid migration to infection sites (IL-8, LTB4, C5a, fMLP gradients).
- Inflammation modulation: Cytokines (TNF-α, IL-1β, IL-8), lipid mediators.
- Adaptive immunity bridge: Antigen presentation, T-cell recruitment, B-cell help.
Clinical Counts (Absolute Neutrophil Count = ANC)
- Normal: 1.5–8.0 ×10³/µL (varies by lab/ethnicity).
- Neutrophilia (>8k): Infection, inflammation, stress, steroids, myeloproliferative neoplasms.
- Neutropenia (<1.5k): Chemo, autoimmune, congenital, drugs, B12/folate deficiency, sepsis (consumption).
- Benign ethnic neutropenia: Common in African, Middle Eastern descent; no infection risk.
Emergency
ANC <0.5k (severe neutropenia) + fever = medical emergency (febrile neutropenia).
Leukemia - Related Articles
- Acute Myeloid Leukemia (AML) Subtypes: Treatment Options & Remission
- Leukemia Treatment Options: Comprehensive Overview by Modality
- Chemists' Contributions to Leukemia Treatment: Drug Development and Innovation
- Leukemia Treatment: Understanding Stem Cell Transplants
- Understanding and Treating Blood Cancers: Options & Approaches
- Myelodysplastic Syndrome (MDS): Understanding Treatment Options & Outlook
- DNA Replication: The S Phase of the Cell Cycle
